OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
ATTBF
Abattis Bioceuticals Corp.
Ordinary Shares
Abattis Bioceuticals Corp.
Suite 1200
625 Howe Street
Vancouver, BC V6C 2T6
Canada
Last Verified 11/2018
Business Description
Abattis is a life sciences and biotechnology company which aggregates, integrates, and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. The Company is also seeking to acquire exclusive intellectual property rights to agricultural technologies to be employed in extraction and processing of botanical ingredients and compounds. The Company follows strict standard operating protocols, and adheres to the applicable laws of Canada and foreign jurisdic ...
More
Financial Reporting
Reporting Status
Dark: Alternative Reporting Standard
Audited Financials
Not Available
Latest Report
CIK
0001515768
Fiscal Year End
9/30
Company Officers & Contacts
Board of Directors
Robert Abenante
CEO, President
Peter Gordon
James Irving
Independent Director, Audit Committee Member
Other Company Insiders
Not available
Service Providers
Accounting/Auditing Firm
Dale Matheson Carr-Hilton Labonte LLP1140 West Pender Street
# 1500-1700
Vancouver, BC V6E EG1
Canada
Securities Counsel
Clark Wilson LLP885 West Georgia Street #900
Vancouver, BC V6C 3H1
Canada
Profile Data
SIC - Industry Classification
2833 - Medicinal and botanicals
Incorporation Information
BC, CA, 1997
Employees
Not Available
Shell
No
Products and Services
Not available
Company Facilities
Not available
Company Notes
Formerly=Abattis Biologix Corp. until 9-2012
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
OTC Markets Group is unable to confirm this company is providing public disclosure to a regulator, an exchange, or OTC Markets Group.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
58.00
Change
0.50 (0.87%)
Bid
58.00
Ask
59.00
Volume
2093
Time
00:00
